Lucid Diagnostics(LUCD) - 2024 Q2 - Quarterly Results
Exhibit 99.1 Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results EsoGuardtest volume increased 31 percent quarterly; 44 percent annually Clinical data now well-positioned for final push towards broad coverage and reimbursement Over 50 high-volume #CheckYourFoodTube Precancer Testing Events in 2Q24, including first with upfront contracted payment Conference call and webcast to be held today, August 12 at 8:30 AM EDT NEW YORK, August 12, 2024 - Lucid Diagnostics Inc. (Nasdaq: ...